Wyden claims Pfizer used a ‘colossal’ scheme to avoid paying billions in U.S. taxes

Taking stock of the drug industry, from the lab to the medicine chest

March 27, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Drew Angerer/Getty Images STAT+ | Wyden claims Pfizer used a 'colossal' scheme to avoid paying billions in U.S. taxes Pfizer allegedly avoided paying U.S. taxes for a three-year period by using a maneuver that allowed it to declare income was earned offshore. By Ed Silverman STAT+ | In a first, Eli Lilly to connect patients to telehealth providers of Alzheimer's care The move by Lilly, which sells a treatment for the condition, is part of a direct-to-consumer push that has drawn scrutiny. By Elaine Chen and Katie Palmer STAT+ | AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery Life sciences data company Apheris announces plan to boost the capabilities of protein AI models using proprietary data from pharma companies. By Brittany Trang Mike Reddy for STAT STAT+ | Burst PIPEs? So-so returns for biotech's once-buzzy financing vehicle In this edition of "Adam's Biotech Scorecard," a closer look at PIPEs, biotech's once-buzzy financing vehicle, and a conversation with the CEO of RegenxBio. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser